Afynia (formerly AIMA Laboratories) is a medical diagnostic company commercializing the first diagnostic blood test for endometriosis. It is estimated that 400 million women are diagnosed each year with chronic pelvic pain of which 50-65% will ultimately be diagnosed with endometriosis. Sadly, it takes between 5 and 12 years from onset of symptoms for a diagnosis. Afynia’s test detects endometriosis with the same accuracy as surgery and provides women and their doctors with actionable data to take back control of their lives.


Lauren Foster

Dr. Lauren Foster


Jocelyn Wessels

Dr. Jocelyn Wessels


Featured Stories

idea fund cohort 2

Five Forge Clients Selected for i.d.e.a. Fund, Showcasing Innovation

This article was has been adapted from its original publication by Innovation Factory. Read the original article. In a testament to...

AIMA Laboratories test kit

Making Women’s Health a Top Priority: AIMA Laboratories and FirstHx form Powerhouse Partnership

Two Ontario-based companies, AIMA Laboratories, and FirstHx are pleased to announce a collaborative partnership to improve the care of people...